English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/91931
Título

Cooperative effect of 5-aminolevulinic acid and gold nanoparticles for photodynamic therapy of cancer

AutorBenito, Marta; Martin, Virginia ; Blanco, M.D.; Teijón, J.M.,; Gómez, C.
Palabras clavephotodynamic therapy
gold nanoparticle
ROS
cytotoxicity
apoptosis
ALA
Fecha de publicación2013
EditorJohn Wiley & Sons
CitaciónJournal of Pharmaceutical Sciences 102: 2760- 2769 (2013)
ResumenAn enhanced capacity for protoporphyrin IX (PpIX) synthesis through 5- aminolevulinic acid (ALA) administration has been reported in cancer cells. We compared the effect of ALA and ALA combined with gold nanoparticles (ALA–AuNPs) for photodynamic ther- apy (PDT) on human cervical cancer cell line. Because PpIX after photoactivation produces reactive oxygen species (ROS), ALA–AuNPs combinations can enhance this production and then induce higher phototoxicity. With this aim, two different-sized AuNPs (14 and 136 nm, AuNP1 and AuNP2, respectively) were successfully synthesized and characterized by UV–visi- ble spectrophotometry and transmission electron microscopy. AuNPs were combined with ALA to evaluate their cooperative action in the intracellular ROS production, cell viability, and cell death mechanism. Results showed that ALA–AuNPs combinations induced cell death via ROS- mediated apoptosis after PDT. When exposed to light at their resonance wavelength, AuNP2 combined with ALA result in cytotoxicity and cell injury in greater extension than ALA and ALA–AuNP1 combination
URIhttp://hdl.handle.net/10261/91931
DOI10.1002/jps.23621
Identificadoresdoi: 10.1002/jps.23621
issn: 0022-3549
Aparece en las colecciones: (IQFR) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.